Home » Topics » BioWorld

BioWorld
RSS

SPAIN APPROVES BTGC'S GROWTH HORMONE

Oct. 9, 1991

RIBI MELANOMA VACCINE ENTERS PHASE III

Oct. 9, 1991

ICN TO COMPLY WITH SEC

Oct. 9, 1991

IDEC MAY HAVE TO LICENSE PATENT

Oct. 9, 1991

NIH FUNDS LIPID-BASED AIDS DRUG

Oct. 9, 1991

CANCER TREATMENT COMBINES THERAPIES

Oct. 9, 1991

ECOGEN SIGNS DISTRIBUTION DEAL

Oct. 8, 1991

GLYCOMED TO FILE 2 MILLION-SHARE OFFERING

Oct. 8, 1991

HIGH COURT REJECTS GI'S EPO PATENT APPEAL

Oct. 8, 1991

Biogen R&D Agreement for Hirulog

Oct. 8, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...